Advertisement

Topics

Fate signs deal with Ono on 2 off-the-shelf CAR T-cell projects

06:49 EDT 19 Sep 2018 | SmartBrief

Fate Therapeutics and Ono Pharmaceutical agreed to work together to develop and market two off-the-shelf chimeric antigen rec -More

Original Article: Fate signs deal with Ono on 2 off-the-shelf CAR T-cell projects

NEXT ARTICLE

More From BioPortfolio on "Fate signs deal with Ono on 2 off-the-shelf CAR T-cell projects"

Advertisement
Quick Search
Advertisement
Advertisement